News | Mammography | September 22, 2023

Partnership includes education and training to increase clinician confidence in the use of CEM, an emerging breast imaging modality 

Partnership includes education and training to increase clinician confidence in the use of CEM, an emerging breast imaging modality

Image courtesy of Hologic 


September 22, 2023 — Hologic Inc. and Bayer announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries across the European, Canadian and Asia Pacific regions. 

CEM is a highly sensitive and relatively low-cost breast imaging modality that combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.1 

The partnership brings together the companies’ leading technologies (Hologic mammography gantries and Bayer CEM-approved injection systems) to enable the administration of contrast media during a mammography examination. With the new agreement, Bayer and Hologic aim to optimally support radiologists and their teams’ needs by providing a comprehensive product package along with the hands-on training needed to effectively implement CEM into their facility’s workflow. 

“Over the past several years, we’ve seen an increased interest in contrast-enhanced mammography as an additional diagnostic modality. Our partnership with Bayer will enable clinicians around the world to offer CEM as part of the breast cancer diagnostic workflow,” said Tanja Brycker, Vice President, Strategic Development, Breast and Skeletal Health and GYN Solutions at Hologic. “As one of the world leaders in mammography and women’s health, we are committed to enabling healthier lives everywhere, every day. By increasing access to additional breast imaging technology to women across the globe, our international partnership with Bayer is a compelling example of that commitment in action.” 

“Breast cancer is the world’s most prevalent cancer,2 impacting millions of women and their loved ones around the globe,” said Gerd Krueger, President of Radiology at Bayer. “Accurate and timely detection is crucial to improve patient outcomes and save patients’ lives. We are excited to join forces with Hologic to deliver a comprehensive solution to our customers and increase access to an emerging breast imaging modality that can help improve diagnostic accuracy as well as provide an alternative imaging option for many women who need it.” 

About Breast Cancer and Contrast-Enhanced Mammography 

In 2020, there were 2.3 million women diagnosed with breast cancer and 685,000 deaths globally, according to the World Health Organization (WHO).2 Breast cancer treatment can be very effective, especially when the disease is identified early. The value of CEM as an adjunct to mammography is affirmed by an increasing number of independent scientific publications. It can be performed as part of an everyday clinical practice and used in various clinical settings, such as inconclusive findings in previous imaging procedures, or preoperative assessment of the extent of the disease. It can also be a helpful tool when MRI is unavailable or contraindicated. 

For more information: www.hologic.com 

 

References: 

1 Covington MF. Contrast-Enhanced Mammography Implementation, Performance, and Use for Supplemental Breast Cancer Screening. Radiol Clin North Am. 2021 Jan;59(1):113-128. doi: 10.1016/j.rcl.2020.08.006. Epub 2020 Oct 29. PMID: 33222993.
2 World Health Organization. Breast Cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer#:~:text=As%20of%20the%20end%20of,increasing%20rates%20in%20later%20life. Last accessed 6 September 2023. 

 

Related Breast Density Content:   

VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule    

One on One … with Wendie Berg, MD, PhD, FACR, FSBI    

Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer    

Creating Patient Equity: A Breast Density Legislative Update    

FDA Needs to Ensure that Information on Dense Breast Notifications are Clear and Understandable to all Members of the Public    

AI Provides Accurate Breast Density Classification    

VIDEO: The Impact of Breast Density Technology and Legislation    

VIDEO: Personalized Breast Screening and Breast Density    

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference    

Fake News: Having Dense Breast Tissue is No Big Deal    

The Manic World of Social Media and Breast Cancer: Gratitude and Grief    

  

Related Breast Imaging Content:   

Saving Lives Through Improved Screening Awareness 

Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast Cancer   

Uncertainty About Breast Cancer Risk and Screening Choices and Perceived Risk Heighten with Breast Density Awareness Following Mammography   

Creating Patient Equity: A Breast Density Legislative Update   

FDA Needs to Ensure that Information on Dense Breast Notifications are Clear and Understandable to all Members of the Public   

AI Provides Accurate Breast Density Classification   

VIDEO: The Impact of Breast Density Technology and Legislation   

VIDEO: Personalized Breast Screening and Breast Density   

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference   

Fake News: Having Dense Breast Tissue is No Big Deal   

The Manic World of Social Media and Breast Cancer: Gratitude and Grief  


Related Content

News | Mammography

Aug. 5, 2025 — New Lantern has announced the launch of two specialized viewer modes: the Mammography Viewer Mode and PET ...

Time August 05, 2025
arrow
News | Breast Imaging

Aug. 1, 2025 — The American Roentgen Ray Society’s American Journal of Roentgenology (AJR) has published a clinically ...

Time August 04, 2025
arrow
News | Breast Imaging

July 29, 2025 — A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman ...

Time July 30, 2025
arrow
News | Advanced Visualization

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Time July 28, 2025
arrow
News | Radiology Imaging

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

Time July 25, 2025
arrow
News | Breast Imaging

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior ...

Time July 09, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Women's Health

June 23, 2025 — Susan G. Komen, the world’s leading breast cancer organization, recently announced it is awarding $10.8 ...

Time June 23, 2025
arrow
Feature | Women's Health | Christine Murray

In breast cancer detection, speed and accuracy are more than clinical goals – they can significantly increase chances ...

Time June 17, 2025
arrow
Subscribe Now